|
Baumann F,Paul T, Wassersleben S, Regenthal
R, Enke D,
Aigner A
Characterization of Drug Release from Mesoporous SiO(2)-Based Membranes
with Variable Pore Structure and Geometry
Pharmaceutics 2022; 14(6): 1184
Borchardt H, Kogel A, Kalwa H,Weirauch
U, Aigner A
Therapeutic miR-506-3p Replacement in Pacreatic Carcinoma Leads
to Multiple Effects including Autophagy, Apoptosis, Senescense,
and Mitochondrial Alterations In Vitro and In Vivo
Biomedicines 2022; 10(7): 1692
Friedrich M, Aigner A
Therapeutic siRNA: State-of-Art and Future Perspectives.
BioDrugs 2022; 36(5): 549-571
Noske S, Karimov M, Hansen M, Zatula N, Ewe
A, Aigner A
Non-viral siRNA transfection of primary mesenchymal stromal cells
(MSCs):
Assessment of tyrosine-modified PEI and PPI efficacy and
biocompatibility.
Int J Pharm 2022; 612: 121359
Chai XN, Ludwig FA, Müglitz A, Gong Y, Schaefer M,
Regenthal
R, Krügel U
A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045
in Mice by LC-MS/MS.
Int J Mol Sci 2022; 23(7): 3635
Friedrich M, Pfeifer G, Binder S, Aigner A, Vollmer
Barbosa P, Makert GR, Fertey J, Ulbert S,
Bodem J, König EM, Geiger N, Schambach A, Schilling E,
Buschmann T, Hauschildt S, Koehl U, Sewald K
Selection and Validation of siRNAs Preventing Uptake and Replication of
SARS-CoV-2
Front Bioeng Biotechnol 2022; 2: 10
Hezemans FH, Wolpe N, O'Callaghan C, Ye R, Rua C, Jones PS, Murley AG,
Holland N,
Regenthal R, Tsvetanov KA, Barker RA,
Williams-Gray CH, Robbins TW, Passamonti L, Rowe JB
Noradrenergic deficits contribute to apathy in Parkinson's disease
through the precision of expected outcomes.
PLoS Comput Biol 2022; 18: 1371
Jugel W, Tietze S, Daeg J, Appelhans D, Broghammer F, Aigner
A, Karimov M, Schackert G, Temme A
Targeted Transposition of Minicircle DNA Using Single-Chain Antibody
Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers.
Cancers (Basel) 2022; 14(8): 1925
Kubczak M, Michlewska S, Karimov M, Ewe A, Noske S, Aigner A,
Bryszewska M, Ionov M
Unmodified and tyrosine-modified polyethylenimines as potential
carriers for siRNA: Biophysical characterization and toxicity.
Int J Pharm 2022; Febr 25; 614: 121468
Mirna M, Paar V, Topf A, Kraus T, Sotlar K, Aigner A, Ewe A,
Watzinger S, Podesser BK, Hackl M, Pistulli R, Hoppe UC,
Kiss A, Lichtenauer M
A new player in the game. treatment with antagomiR-21a-5p significantly
attenuates histological and echocardiographic effects of experimental
autoimmune myocarditis.
Cardiovasc Res 2022; 29: 556-572
Mitrach F, Schmid M, Toussaint M, Dukic-Stefanovic S, Deuther-Conrad W,
Franke H,
Ewe A, Aigner A, Wölk C, Brust P,
Hacker MC, Schulz-Siegmund M,
Amphiphilic Anionic Oligomer-Stabilized Calcium Phospate Nanoparticles
with
Prospects in siRNA Delivery via Convection-Enhanced Delivery.
Pharmaceutics 2022; 14: 326
Remy J, Linder B, Weirauch U, Day BW, Stringer BW,
Herold-Mende C, Aigner A, Krohn K, Kögel D
STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced
Autophagy-Dependent Cell Death.
Cancers (Basel) 2022; 14(2): 339
Rode M, Nenoff K, Wirkner K, Horn K, Teren A, Regenthal R,
Loeffler M, Thiery J, Aigner A, Pott J, Kirsten H,
Scholz M
Impact of medication on blood transcription reveals off-target
regulations
of beta-blockers.
PLos One 2022; 17(4):1932
Schellenberg LM, Regenthal R, Abraham G
Corrigendum to:"The Rho kinase (ROCK) inhibitor Y-27632 reduces the
beta 2-adrenoceptor density
but enhance cAMP formation in primary equine bronchial epithelial
cells"[Eur J Pharmacol 2021 Sept 15; 907: 174323].
Eur J Pharmacol 2022; 915: 174724
Schinke C, Rullmann M, Luthardt J, Drabe M, Preller E, Becker GA, Patt M, Regenthal
R, Zientek F, Sabri O, Then Bergh F, Hesse S
HPA Axis Resonsiveness Associates with Central Serotonin Transporter
Availability in Human Obesity and Non-Obesity Controls
Brain Sci 2022; 12(11): 1430
Ye R, Mazibuko N, Teichert J, Regenthal R, Kehagia
AA, Mehta MA
Mapping the effects of atomoxetine during response inhibition across
cortical territories and the locus coeruleus.
Psychopharmacology 2022; 239: 365-376
Zsido RG, Molloy EN, Cesnaite E, Zheleva G, Beinhölzl N,
Scharrer U, Piecha FA, Regenthal R, Villringer A,
Nikulin VV, Sacher J
One-week escitalopram intake alters the excitation-inhibition balance
in the healthy female brain
Hum Brain Mapp 2022; 43: 1868-1881
|